Healthcare provider profile · identity verified

Max Adler Chancy, MD

Family Practice · COVINA, CA · NPI 1457998890

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	453	199
Losartan Potassium	Losartan Potassium	400	158
Gabapentin	Gabapentin	252	134
Amlodipine Besylate	Amlodipine Besylate	240	92
Metformin Hcl	Metformin Hcl	232	103
Lisinopril	Lisinopril	196	78
Tamsulosin Hcl	Tamsulosin Hcl	180	72
Metoprolol Succinate	Metoprolol Succinate	172	66
Levothyroxine Sodium	Levothyroxine Sodium	171	66
Rosuvastatin Calcium	Rosuvastatin Calcium	148	56
Simvastatin	Simvastatin	120	50
Furosemide	Furosemide	111	49
Carvedilol	Carvedilol	101	39
Fluticasone Propionate	Fluticasone Propionate	96	47
Hydrochlorothiazide	Hydrochlorothiazide	91	43
Ozempic	Semaglutide	85	18
Jardiance	Empagliflozin	80	30
Omeprazole	Omeprazole	75	44
Albuterol Sulfate Hfa	Albuterol Sulfate	73	40
Eliquis	Apixaban	72	28
Alendronate Sodium	Alendronate Sodium	70	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	19
Diclofenac Sodium	Diclofenac Sodium	58	28
Duloxetine Hcl	Duloxetine Hcl	55	23
Triamcinolone Acetonide	Triamcinolone Acetonide	54	31
Chlorthalidone	Chlorthalidone	51	27
Finasteride	Finasteride	51	17
Valsartan	Valsartan	50	19
Atenolol	Atenolol	49	25
Oxybutynin Chloride Er	Oxybutynin Chloride	47	13
Mirtazapine	Mirtazapine	45	16
Escitalopram Oxalate	Escitalopram Oxalate	44	17
Allopurinol	Allopurinol	43	19
Benazepril Hcl	Benazepril Hcl	42	16
Glipizide	Glipizide	41	19
Pravastatin Sodium	Pravastatin Sodium	41	20
Glimepiride	Glimepiride	37	suppressed
Sertraline Hcl	Sertraline Hcl	36	17
Lovastatin	Lovastatin	34	14
Donepezil Hcl	Donepezil Hcl	33	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	31	15
Sildenafil Citrate	Sildenafil Citrate	29	suppressed
Farxiga	Dapagliflozin Propanediol	28	13
Januvia	Sitagliptin Phosphate	27	14
Wixela Inhub	Fluticasone Propion/Salmeterol	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	14
Meloxicam	Meloxicam	26	17
Terazosin Hcl	Terazosin Hcl	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	25	15
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Famotidine	Famotidine	23	13
Glipizide Er	Glipizide	23	11
Ezetimibe	Ezetimibe	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	11
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Trazodone Hcl	Trazodone Hcl	21	suppressed
Baclofen	Baclofen	20	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	11
Enalapril Maleate	Enalapril Maleate	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	11
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Sucralfate	Sucralfate	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Fluconazole	Fluconazole	13	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error